Furthermore, administration of recombinant ANGPTL4 was effective as a treatment for acute myocardial infarction because it counteracts the increase in permeability observed in re-perfused acute myocardial infarction [35]. The gene discussed is ANGPTL4; the disease is myocardial infarction.